nodes	percent_of_prediction	percent_of_DWPC	metapath
Pefloxacin—TOP2A—hematologic cancer	0.39	1	CbGaD
Pefloxacin—TOP2A—Idarubicin—hematologic cancer	0.12	0.209	CbGbCtD
Pefloxacin—TOP2A—Daunorubicin—hematologic cancer	0.0847	0.148	CbGbCtD
Pefloxacin—TOP2A—Teniposide—hematologic cancer	0.0736	0.129	CbGbCtD
Pefloxacin—TOP2A—Mitoxantrone—hematologic cancer	0.0515	0.0899	CbGbCtD
Pefloxacin—TOP2A—Epirubicin—hematologic cancer	0.0417	0.0728	CbGbCtD
Pefloxacin—TOP2A—Etoposide—hematologic cancer	0.0325	0.0567	CbGbCtD
Pefloxacin—CYP1A2—Anagrelide—hematologic cancer	0.0319	0.0557	CbGbCtD
Pefloxacin—TOP2A—Doxorubicin—hematologic cancer	0.0221	0.0387	CbGbCtD
Pefloxacin—CYP1A2—Carmustine—hematologic cancer	0.0168	0.0292	CbGbCtD
Pefloxacin—CYP1A2—Methoxsalen—hematologic cancer	0.0142	0.0249	CbGbCtD
Pefloxacin—CYP1A2—Bortezomib—hematologic cancer	0.0136	0.0237	CbGbCtD
Pefloxacin—CYP1A2—Daunorubicin—hematologic cancer	0.013	0.0226	CbGbCtD
Pefloxacin—CYP1A2—Alitretinoin—hematologic cancer	0.0127	0.0222	CbGbCtD
Pefloxacin—CYP1A2—Thalidomide—hematologic cancer	0.0118	0.0206	CbGbCtD
Pefloxacin—CYP1A2—Dacarbazine—hematologic cancer	0.0102	0.0177	CbGbCtD
Pefloxacin—CYP1A2—Imatinib—hematologic cancer	0.00993	0.0173	CbGbCtD
Pefloxacin—CYP1A2—Dasatinib—hematologic cancer	0.00797	0.0139	CbGbCtD
Pefloxacin—CYP1A2—Etoposide—hematologic cancer	0.00497	0.00867	CbGbCtD
Pefloxacin—Enoxacin—TOP2A—hematologic cancer	0.000542	0.201	CrCbGaD
Pefloxacin—Lomefloxacin—TOP2A—hematologic cancer	0.000411	0.152	CrCbGaD
Pefloxacin—Levofloxacin—TOP2A—hematologic cancer	0.000351	0.13	CrCbGaD
Pefloxacin—Ofloxacin—TOP2A—hematologic cancer	0.000351	0.13	CrCbGaD
Pefloxacin—Ciprofloxacin—TOP2A—hematologic cancer	0.000339	0.125	CrCbGaD
Pefloxacin—TOP2A—Nilotinib—Imatinib—hematologic cancer	0.000315	0.0778	CbGdCrCtD
Pefloxacin—Norfloxacin—TOP2A—hematologic cancer	0.000285	0.105	CrCbGaD
Pefloxacin—Gatifloxacin—ALB—hematologic cancer	0.000228	0.0843	CrCbGaD
Pefloxacin—TOP2A—Topotecan—Irinotecan—hematologic cancer	0.000175	0.0432	CbGdCrCtD
Pefloxacin—TOP2A—Etoposide—Teniposide—hematologic cancer	0.000174	0.0429	CbGdCrCtD
Pefloxacin—TOP2A—Vindesine—Vinorelbine—hematologic cancer	0.000156	0.0386	CbGdCrCtD
Pefloxacin—TOP2A—Podofilox—Teniposide—hematologic cancer	0.000132	0.0327	CbGdCrCtD
Pefloxacin—TOP2A—Vindesine—Vinblastine—hematologic cancer	0.000125	0.0308	CbGdCrCtD
Pefloxacin—TOP2A—Vindesine—Vincristine—hematologic cancer	0.000125	0.0308	CbGdCrCtD
Pefloxacin—TOP2A—Floxuridine—Pentostatin—hematologic cancer	0.00012	0.0297	CbGdCrCtD
Pefloxacin—TOP2A—Epirubicin—Daunorubicin—hematologic cancer	0.000118	0.0291	CbGdCrCtD
Pefloxacin—TOP2A—Idarubicin—Daunorubicin—hematologic cancer	0.000118	0.0291	CbGdCrCtD
Pefloxacin—TOP2A—Doxorubicin—Daunorubicin—hematologic cancer	0.000118	0.0291	CbGdCrCtD
Pefloxacin—TOP2A—Menadione—Thalidomide—hematologic cancer	0.0001	0.0248	CbGdCrCtD
Pefloxacin—Levofloxacin—ABCB1—hematologic cancer	9.99e-05	0.0369	CrCbGaD
Pefloxacin—Ciprofloxacin—ABCB1—hematologic cancer	9.65e-05	0.0357	CrCbGaD
Pefloxacin—TOP2A—Cladribine—Pentostatin—hematologic cancer	9.11e-05	0.0225	CbGdCrCtD
Pefloxacin—TOP2A—Daunorubicin—Idarubicin—hematologic cancer	8.94e-05	0.0221	CbGdCrCtD
Pefloxacin—TOP2A—Epirubicin—Idarubicin—hematologic cancer	8.94e-05	0.0221	CbGdCrCtD
Pefloxacin—TOP2A—Doxorubicin—Idarubicin—hematologic cancer	8.94e-05	0.0221	CbGdCrCtD
Pefloxacin—TOP2A—Mitotic G1-G1/S phases—CDK2—hematologic cancer	8.76e-05	0.00286	CbGpPWpGaD
Pefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—MDM2—hematologic cancer	8.72e-05	0.00285	CbGpPWpGaD
Pefloxacin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—hematologic cancer	8.56e-05	0.0028	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—NQO1—hematologic cancer	8.51e-05	0.00279	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—NQO1—hematologic cancer	8.51e-05	0.00279	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—STAT5A—hematologic cancer	8.45e-05	0.00277	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ABL1—hematologic cancer	8.45e-05	0.00277	CbGpPWpGaD
Pefloxacin—TOP2A—Vincristine—Vinorelbine—hematologic cancer	8.43e-05	0.0208	CbGdCrCtD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN2B—hematologic cancer	8.38e-05	0.00274	CbGpPWpGaD
Pefloxacin—TOP2A—Mitotic G1-G1/S phases—CDK4—hematologic cancer	8.28e-05	0.00271	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—ATR—hematologic cancer	8.19e-05	0.00268	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ABCB1—hematologic cancer	8.19e-05	0.00268	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle, Mitotic—STAG2—hematologic cancer	8.17e-05	0.00267	CbGpPWpGaD
Pefloxacin—TOP2A—Cladribine—Clofarabine—hematologic cancer	8.12e-05	0.0201	CbGdCrCtD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—HSP90AA1—hematologic cancer	8.01e-05	0.00262	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HSP90AA1—hematologic cancer	8.01e-05	0.00262	CbGpPWpGaD
Pefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CDKN1B—hematologic cancer	7.96e-05	0.0026	CbGpPWpGaD
Pefloxacin—CYP1A2—Estrogen Receptor Pathway—STAT3—hematologic cancer	7.89e-05	0.00258	CbGpPWpGaD
Pefloxacin—TOP2A—Vinorelbine—Vinblastine—hematologic cancer	7.88e-05	0.0195	CbGdCrCtD
Pefloxacin—TOP2A—Vinorelbine—Vincristine—hematologic cancer	7.88e-05	0.0195	CbGdCrCtD
Pefloxacin—TOP2A—Podofilox—Etoposide—hematologic cancer	7.87e-05	0.0194	CbGdCrCtD
Pefloxacin—TOP2A—Teniposide—Etoposide—hematologic cancer	7.87e-05	0.0194	CbGdCrCtD
Pefloxacin—CYP1A2—Phase II conjugation—GSTO1—hematologic cancer	7.86e-05	0.00257	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—FGF1—hematologic cancer	7.86e-05	0.00257	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BAX—hematologic cancer	7.75e-05	0.00253	CbGpPWpGaD
Pefloxacin—TOP2A—Cladribine—Nelarabine—hematologic cancer	7.64e-05	0.0189	CbGdCrCtD
Pefloxacin—TOP2A—Circadian rythm related genes—NCOR1—hematologic cancer	7.63e-05	0.0025	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PDGFRA—hematologic cancer	7.61e-05	0.00249	CbGpPWpGaD
Pefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CCND1—hematologic cancer	7.6e-05	0.00248	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle, Mitotic—FOXM1—hematologic cancer	7.47e-05	0.00244	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle, Mitotic—H3F3B—hematologic cancer	7.47e-05	0.00244	CbGpPWpGaD
Pefloxacin—CYP1A2—Phase II conjugation—UGT1A1—hematologic cancer	7.39e-05	0.00242	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—FASLG—hematologic cancer	7.39e-05	0.00242	CbGpPWpGaD
Pefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CDKN1A—hematologic cancer	7.35e-05	0.0024	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—STAG2—hematologic cancer	7.3e-05	0.00239	CbGpPWpGaD
Pefloxacin—TOP2A—Circadian rythm related genes—PRKCG—hematologic cancer	7.28e-05	0.00238	CbGpPWpGaD
Pefloxacin—TOP2A—Floxuridine—Cladribine—hematologic cancer	7.25e-05	0.0179	CbGdCrCtD
Pefloxacin—TOP2A—Mitotic G1-G1/S phases—RB1—hematologic cancer	7.2e-05	0.00235	CbGpPWpGaD
Pefloxacin—CYP1A2—Biological oxidations—SLC35B2—hematologic cancer	7.14e-05	0.00234	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—FAS—hematologic cancer	7.13e-05	0.00233	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle, Mitotic—CCND3—hematologic cancer	7.06e-05	0.00231	CbGpPWpGaD
Pefloxacin—TOP2A—Clofarabine—Nelarabine—hematologic cancer	7.06e-05	0.0174	CbGdCrCtD
Pefloxacin—CYP1A2—Metapathway biotransformation—EPHX1—hematologic cancer	7.04e-05	0.0023	CbGpPWpGaD
Pefloxacin—TOP2A—Circadian rythm related genes—FAS—hematologic cancer	6.84e-05	0.00224	CbGpPWpGaD
Pefloxacin—TOP2A—Vinblastine—Vinorelbine—hematologic cancer	6.78e-05	0.0167	CbGdCrCtD
Pefloxacin—TOP2A—Vincristine—Vinblastine—hematologic cancer	6.74e-05	0.0166	CbGdCrCtD
Pefloxacin—TOP2A—Cell Cycle, Mitotic—NUP98—hematologic cancer	6.73e-05	0.0022	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—FOXM1—hematologic cancer	6.68e-05	0.00219	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—H3F3B—hematologic cancer	6.68e-05	0.00219	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDK2—hematologic cancer	6.63e-05	0.00217	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—hematologic cancer	6.56e-05	0.00215	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle, Mitotic—NUP214—hematologic cancer	6.48e-05	0.00212	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—NPM1—hematologic cancer	6.43e-05	0.0021	CbGpPWpGaD
Pefloxacin—CYP1A2—Phase II conjugation—MTR—hematologic cancer	6.41e-05	0.0021	CbGpPWpGaD
Pefloxacin—TOP2A—Cytarabine—Clofarabine—hematologic cancer	6.39e-05	0.0158	CbGdCrCtD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK14—hematologic cancer	6.37e-05	0.00208	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—BAX—hematologic cancer	6.36e-05	0.00208	CbGpPWpGaD
Pefloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN2A—hematologic cancer	6.33e-05	0.00207	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—CCND3—hematologic cancer	6.32e-05	0.00207	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ATM—hematologic cancer	6.3e-05	0.00206	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDK4—hematologic cancer	6.27e-05	0.00205	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ESR1—hematologic cancer	6.24e-05	0.00204	CbGpPWpGaD
Pefloxacin—CYP1A2—Phase II conjugation—GSTT1—hematologic cancer	6.1e-05	0.00199	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BAD—hematologic cancer	6.09e-05	0.00199	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—NFKBIA—hematologic cancer	6.09e-05	0.00199	CbGpPWpGaD
Pefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—MYC—hematologic cancer	6.09e-05	0.00199	CbGpPWpGaD
Pefloxacin—TOP2A—Circadian rythm related genes—CDK4—hematologic cancer	6.02e-05	0.00197	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—NUP98—hematologic cancer	6.01e-05	0.00197	CbGpPWpGaD
Pefloxacin—TOP2A—Cytarabine—Nelarabine—hematologic cancer	6.01e-05	0.0148	CbGdCrCtD
Pefloxacin—TOP2A—Cladribine—Fludarabine—hematologic cancer	5.96e-05	0.0147	CbGdCrCtD
Pefloxacin—TOP2A—Cell Cycle—NUP214—hematologic cancer	5.8e-05	0.0019	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle, Mitotic—SMC1A—hematologic cancer	5.72e-05	0.00187	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CREB1—hematologic cancer	5.62e-05	0.00184	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle, Mitotic—H3F3A—hematologic cancer	5.61e-05	0.00183	CbGpPWpGaD
Pefloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN1B—hematologic cancer	5.6e-05	0.00183	CbGpPWpGaD
Pefloxacin—TOP2A—Clofarabine—Fludarabine—hematologic cancer	5.51e-05	0.0136	CbGdCrCtD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CASP8—hematologic cancer	5.5e-05	0.0018	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CREBBP—hematologic cancer	5.47e-05	0.00179	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—CDK2—hematologic cancer	5.45e-05	0.00178	CbGpPWpGaD
Pefloxacin—TOP2A—Vinblastine—Vincristine—hematologic cancer	5.42e-05	0.0134	CbGdCrCtD
Pefloxacin—TOP2A—Circadian rythm related genes—CREB1—hematologic cancer	5.39e-05	0.00176	CbGpPWpGaD
Pefloxacin—TOP2A—Mitotic G1-G1/S phases—CCND1—hematologic cancer	5.34e-05	0.00175	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—MLH1—hematologic cancer	5.34e-05	0.00175	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle, Mitotic—CDK6—hematologic cancer	5.26e-05	0.00172	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MAP2K1—hematologic cancer	5.22e-05	0.00171	CbGpPWpGaD
Pefloxacin—TOP2A—Clofarabine—Cytarabine—hematologic cancer	5.2e-05	0.0129	CbGdCrCtD
Pefloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN1A—hematologic cancer	5.17e-05	0.00169	CbGpPWpGaD
Pefloxacin—TOP2A—Azacitidine—Pentostatin—hematologic cancer	5.14e-05	0.0127	CbGdCrCtD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—hematologic cancer	5.13e-05	0.00168	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—SMC1A—hematologic cancer	5.11e-05	0.00167	CbGpPWpGaD
Pefloxacin—TOP2A—Clofarabine—Cladribine—hematologic cancer	5.07e-05	0.0125	CbGdCrCtD
Pefloxacin—TOP2A—Cell Cycle—H3F3A—hematologic cancer	5.01e-05	0.00164	CbGpPWpGaD
Pefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—hematologic cancer	5e-05	0.00164	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—FGF2—hematologic cancer	4.97e-05	0.00163	CbGpPWpGaD
Pefloxacin—TOP2A—Gemcitabine—Cytarabine—hematologic cancer	4.82e-05	0.0119	CbGdCrCtD
Pefloxacin—TOP2A—Cell Cycle, Mitotic—HSP90AA1—hematologic cancer	4.72e-05	0.00154	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BCL2—hematologic cancer	4.72e-05	0.00154	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—CDK6—hematologic cancer	4.71e-05	0.00154	CbGpPWpGaD
Pefloxacin—TOP2A—Cytarabine—Fludarabine—hematologic cancer	4.69e-05	0.0116	CbGdCrCtD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MDM2—hematologic cancer	4.65e-05	0.00152	CbGpPWpGaD
Pefloxacin—CYP1A2—Biological oxidations—GSTO1—hematologic cancer	4.6e-05	0.00151	CbGpPWpGaD
Pefloxacin—TOP2A—Azacitidine—Clofarabine—hematologic cancer	4.58e-05	0.0113	CbGdCrCtD
Pefloxacin—CYP1A2—Metapathway biotransformation—GSTO1—hematologic cancer	4.54e-05	0.00148	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle, Mitotic—CCND2—hematologic cancer	4.53e-05	0.00148	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—RB1—hematologic cancer	4.48e-05	0.00146	CbGpPWpGaD
Pefloxacin—TOP2A—Cytarabine—Gemcitabine—hematologic cancer	4.43e-05	0.0109	CbGdCrCtD
Pefloxacin—CYP1A2—Biological oxidations—UGT1A1—hematologic cancer	4.33e-05	0.00142	CbGpPWpGaD
Pefloxacin—TOP2A—Azacitidine—Nelarabine—hematologic cancer	4.31e-05	0.0106	CbGdCrCtD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—MAP2K1—hematologic cancer	4.29e-05	0.0014	CbGpPWpGaD
Pefloxacin—TOP2A—Mitotic G1-G1/S phases—MYC—hematologic cancer	4.29e-05	0.0014	CbGpPWpGaD
Pefloxacin—CYP1A2—Metapathway biotransformation—UGT1A1—hematologic cancer	4.27e-05	0.0014	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PHYH—hematologic cancer	4.25e-05	0.00139	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1B—hematologic cancer	4.24e-05	0.00139	CbGpPWpGaD
Pefloxacin—CYP1A2—Phase II conjugation—GSTP1—hematologic cancer	4.23e-05	0.00138	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—HSP90AA1—hematologic cancer	4.22e-05	0.00138	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CASP3—hematologic cancer	4.16e-05	0.00136	CbGpPWpGaD
Pefloxacin—TOP2A—Doxorubicin—Epirubicin—hematologic cancer	4.11e-05	0.0101	CbGdCrCtD
Pefloxacin—TOP2A—Idarubicin—Epirubicin—hematologic cancer	4.11e-05	0.0101	CbGdCrCtD
Pefloxacin—TOP2A—Daunorubicin—Epirubicin—hematologic cancer	4.11e-05	0.0101	CbGdCrCtD
Pefloxacin—TOP2A—Cell Cycle, Mitotic—CDKN2B—hematologic cancer	4.06e-05	0.00133	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—hematologic cancer	4.05e-05	0.00132	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—CCND2—hematologic cancer	4.05e-05	0.00132	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—JUN—hematologic cancer	4.04e-05	0.00132	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1A—hematologic cancer	3.92e-05	0.00128	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTEN—hematologic cancer	3.91e-05	0.00128	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—SMPD3—hematologic cancer	3.89e-05	0.00127	CbGpPWpGaD
Pefloxacin—CYP1A2—Phase II conjugation—GSTM1—hematologic cancer	3.88e-05	0.00127	CbGpPWpGaD
Pefloxacin—TOP2A—Circadian rythm related genes—JUN—hematologic cancer	3.88e-05	0.00127	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—hematologic cancer	3.84e-05	0.00126	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK8—hematologic cancer	3.82e-05	0.00125	CbGpPWpGaD
Pefloxacin—CYP1A2—Tryptophan metabolism—MDM2—hematologic cancer	3.82e-05	0.00125	CbGpPWpGaD
Pefloxacin—TOP2A—Epirubicin—Doxorubicin—hematologic cancer	3.8e-05	0.00939	CbGdCrCtD
Pefloxacin—TOP2A—Idarubicin—Doxorubicin—hematologic cancer	3.8e-05	0.00939	CbGdCrCtD
Pefloxacin—TOP2A—Daunorubicin—Doxorubicin—hematologic cancer	3.8e-05	0.00939	CbGdCrCtD
Pefloxacin—TOP2A—Circadian rythm related genes—PTEN—hematologic cancer	3.75e-05	0.00123	CbGpPWpGaD
Pefloxacin—CYP1A2—Biological oxidations—MTR—hematologic cancer	3.75e-05	0.00123	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EP300—hematologic cancer	3.73e-05	0.00122	CbGpPWpGaD
Pefloxacin—TOP2A—Circadian rythm related genes—MAPK8—hematologic cancer	3.67e-05	0.0012	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—CDKN2B—hematologic cancer	3.63e-05	0.00119	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—SRC—hematologic cancer	3.62e-05	0.00119	CbGpPWpGaD
Pefloxacin—TOP2A—Circadian rythm related genes—EP300—hematologic cancer	3.58e-05	0.00117	CbGpPWpGaD
Pefloxacin—CYP1A2—Biological oxidations—GSTT1—hematologic cancer	3.57e-05	0.00117	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—hematologic cancer	3.53e-05	0.00115	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle, Mitotic—BIRC5—hematologic cancer	3.5e-05	0.00115	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—hematologic cancer	3.48e-05	0.00114	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—hematologic cancer	3.48e-05	0.00114	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—hematologic cancer	3.42e-05	0.00112	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—hematologic cancer	3.41e-05	0.00112	CbGpPWpGaD
Pefloxacin—TOP2A—Azacitidine—Fludarabine—hematologic cancer	3.36e-05	0.0083	CbGdCrCtD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK3—hematologic cancer	3.34e-05	0.00109	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—hematologic cancer	3.32e-05	0.00109	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—hematologic cancer	3.25e-05	0.00106	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TGFB1—hematologic cancer	3.24e-05	0.00106	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—hematologic cancer	3.22e-05	0.00105	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle, Mitotic—CDK2—hematologic cancer	3.21e-05	0.00105	CbGpPWpGaD
Pefloxacin—TOP2A—Azacitidine—Gemcitabine—hematologic cancer	3.17e-05	0.00784	CbGdCrCtD
Pefloxacin—TOP2A—Azacitidine—Cytarabine—hematologic cancer	3.17e-05	0.00784	CbGdCrCtD
Pefloxacin—TOP2A—Cell Cycle—BIRC5—hematologic cancer	3.13e-05	0.00102	CbGpPWpGaD
Pefloxacin—TOP2A—Azacitidine—Cladribine—hematologic cancer	3.09e-05	0.00764	CbGdCrCtD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—hematologic cancer	3.06e-05	0.001	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—EP300—hematologic cancer	3.06e-05	0.001	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle, Mitotic—CDK4—hematologic cancer	3.04e-05	0.000993	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—TERT—hematologic cancer	3.03e-05	0.000992	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—hematologic cancer	3.03e-05	0.00099	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—hematologic cancer	3e-05	0.000982	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—SRC—hematologic cancer	2.98e-05	0.000973	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—hematologic cancer	2.98e-05	0.000973	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—hematologic cancer	2.9e-05	0.000948	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—CDK2—hematologic cancer	2.87e-05	0.000939	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—hematologic cancer	2.86e-05	0.000937	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	2.76e-05	0.000902	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—GBA—hematologic cancer	2.74e-05	0.000897	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—ATM—hematologic cancer	2.73e-05	0.000892	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—CDK4—hematologic cancer	2.71e-05	0.000888	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	2.67e-05	0.000873	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—MYC—hematologic cancer	2.67e-05	0.000872	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—hematologic cancer	2.66e-05	0.00087	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle, Mitotic—RB1—hematologic cancer	2.64e-05	0.000863	CbGpPWpGaD
Pefloxacin—TOP2A—Circadian rythm related genes—TP53—hematologic cancer	2.56e-05	0.000838	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—hematologic cancer	2.48e-05	0.000813	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—hematologic cancer	2.48e-05	0.000813	CbGpPWpGaD
Pefloxacin—CYP1A2—Biological oxidations—GSTP1—hematologic cancer	2.47e-05	0.000809	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—hematologic cancer	2.46e-05	0.000806	CbGpPWpGaD
Pefloxacin—CYP1A2—Metapathway biotransformation—GSTP1—hematologic cancer	2.44e-05	0.000798	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—RB1—hematologic cancer	2.36e-05	0.000772	CbGpPWpGaD
Pefloxacin—TOP2A—Circadian rythm related genes—IL6—hematologic cancer	2.34e-05	0.000767	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle, Mitotic—CDKN2A—hematologic cancer	2.32e-05	0.000759	CbGpPWpGaD
Pefloxacin—CYP1A2—Biological oxidations—GSTM1—hematologic cancer	2.27e-05	0.000743	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	2.25e-05	0.000737	CbGpPWpGaD
Pefloxacin—CYP1A2—Metapathway biotransformation—GSTM1—hematologic cancer	2.24e-05	0.000733	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—FHL2—hematologic cancer	2.23e-05	0.000731	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—hematologic cancer	2.09e-05	0.000685	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—CDKN2A—hematologic cancer	2.07e-05	0.000679	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle, Mitotic—CDKN1B—hematologic cancer	2.05e-05	0.000672	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—MDM2—hematologic cancer	2.01e-05	0.000658	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle, Mitotic—CCND1—hematologic cancer	1.96e-05	0.000641	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—ARNTL—hematologic cancer	1.95e-05	0.000639	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle, Mitotic—CDKN1A—hematologic cancer	1.9e-05	0.00062	CbGpPWpGaD
Pefloxacin—TOP2A—Methyltestosterone—Prednisone—hematologic cancer	1.9e-05	0.00468	CbGdCrCtD
Pefloxacin—CYP1A2—Metabolism—GMPS—hematologic cancer	1.89e-05	0.00062	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—FTCD—hematologic cancer	1.89e-05	0.00062	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—PHYH—hematologic cancer	1.89e-05	0.00062	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—NCOR2—hematologic cancer	1.88e-05	0.000614	CbGpPWpGaD
Pefloxacin—TOP2A—Methyltestosterone—Prednisolone—hematologic cancer	1.85e-05	0.00457	CbGdCrCtD
Pefloxacin—TOP2A—Cell Cycle—CDKN1B—hematologic cancer	1.84e-05	0.000601	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle, Mitotic—EP300—hematologic cancer	1.8e-05	0.00059	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—hematologic cancer	1.79e-05	0.000585	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—ABCC3—hematologic cancer	1.77e-05	0.000578	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—CCND1—hematologic cancer	1.75e-05	0.000573	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—SMPD3—hematologic cancer	1.73e-05	0.000567	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—SPHK1—hematologic cancer	1.73e-05	0.000566	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—CDKN1A—hematologic cancer	1.7e-05	0.000555	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle, Mitotic—MAPK3—hematologic cancer	1.62e-05	0.000529	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—hematologic cancer	1.62e-05	0.000529	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—EP300—hematologic cancer	1.61e-05	0.000528	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—ALOX5—hematologic cancer	1.57e-05	0.000515	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle, Mitotic—MYC—hematologic cancer	1.57e-05	0.000514	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—ASNS—hematologic cancer	1.51e-05	0.000496	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—B3GAT1—hematologic cancer	1.51e-05	0.000496	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—DCK—hematologic cancer	1.51e-05	0.000496	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—NCOA3—hematologic cancer	1.48e-05	0.000484	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—MAPK3—hematologic cancer	1.45e-05	0.000473	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—HDC—hematologic cancer	1.44e-05	0.00047	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—MYC—hematologic cancer	1.41e-05	0.00046	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	1.34e-05	0.000438	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—CDA—hematologic cancer	1.31e-05	0.00043	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—PC—hematologic cancer	1.26e-05	0.000414	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—GBA—hematologic cancer	1.22e-05	0.000399	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—SLC35B2—hematologic cancer	1.22e-05	0.000399	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—TP53—hematologic cancer	1.15e-05	0.000378	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—MTAP—hematologic cancer	1.12e-05	0.000365	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—FHL2—hematologic cancer	9.95e-06	0.000326	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—AGRN—hematologic cancer	9.76e-06	0.000319	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—IDH2—hematologic cancer	9.25e-06	0.000303	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—HMMR—hematologic cancer	9.25e-06	0.000303	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	8.73e-06	0.000285	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—ARNTL—hematologic cancer	8.7e-06	0.000285	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—CA9—hematologic cancer	8.46e-06	0.000277	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—ACP5—hematologic cancer	8.46e-06	0.000277	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—NCOR2—hematologic cancer	8.35e-06	0.000273	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—IDH1—hematologic cancer	7.96e-06	0.00026	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—GSTO1—hematologic cancer	7.87e-06	0.000257	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—ABCC3—hematologic cancer	7.87e-06	0.000257	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—TXN—hematologic cancer	7.87e-06	0.000257	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—SPHK1—hematologic cancer	7.7e-06	0.000252	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—UGT1A1—hematologic cancer	7.4e-06	0.000242	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—SLC22A1—hematologic cancer	7.2e-06	0.000235	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—CRABP1—hematologic cancer	7.2e-06	0.000235	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—ALOX5—hematologic cancer	7.01e-06	0.000229	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—NUP98—hematologic cancer	6.79e-06	0.000222	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—ADCY7—hematologic cancer	6.59e-06	0.000216	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—NCOA3—hematologic cancer	6.59e-06	0.000216	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—NUP214—hematologic cancer	6.55e-06	0.000214	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	6.48e-06	0.000212	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—ABCG2—hematologic cancer	6.41e-06	0.00021	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—MTR—hematologic cancer	6.41e-06	0.00021	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—ENO2—hematologic cancer	6.29e-06	0.000206	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—GSTT1—hematologic cancer	6.1e-06	0.0002	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	6.01e-06	0.000197	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—SDC1—hematologic cancer	5.96e-06	0.000195	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	5.7e-06	0.000186	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	5.62e-06	0.000184	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	5.38e-06	0.000176	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—CD44—hematologic cancer	5.07e-06	0.000166	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—NQO1—hematologic cancer	5.07e-06	0.000166	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	4.96e-06	0.000162	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—CYCS—hematologic cancer	4.8e-06	0.000157	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—HSP90AA1—hematologic cancer	4.77e-06	0.000156	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	4.29e-06	0.00014	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—GSTP1—hematologic cancer	4.23e-06	0.000138	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	4.09e-06	0.000134	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—ABCB1—hematologic cancer	4e-06	0.000131	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—NCOR1—hematologic cancer	3.89e-06	0.000127	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—GSTM1—hematologic cancer	3.89e-06	0.000127	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—MTHFR—hematologic cancer	3.43e-06	0.000112	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.03e-06	9.9e-05	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—PIK3CG—hematologic cancer	2.89e-06	9.44e-05	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—CREBBP—hematologic cancer	2.68e-06	8.75e-05	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—PIK3CD—hematologic cancer	2.54e-06	8.3e-05	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—ALB—hematologic cancer	2.5e-06	8.19e-05	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—PIK3R1—hematologic cancer	2.4e-06	7.84e-05	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—PIK3CB—hematologic cancer	2.21e-06	7.23e-05	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—PTEN—hematologic cancer	1.91e-06	6.25e-05	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—EP300—hematologic cancer	1.82e-06	5.96e-05	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—PIK3CA—hematologic cancer	1.35e-06	4.41e-05	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—AKT1—hematologic cancer	1.1e-06	3.6e-05	CbGpPWpGaD
